Please provide your email address to receive an email when new articles are posted on . A prospective comparative case series of 50 patients implanted bilaterally ...

GAITHERSBURG, Md. — In an overwhelming panel vote, the U.S. Food and Drug Administration Ophthalmic Devices Panel of the Medical Devices Advisory Committee voted to recommend Alcon’s premarket ...

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...

Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...

FORT WORTH, Texas--(BUSINESS WIRE)--May 21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the Centers for Medicare and Medicaid Services (CMS) recognized the AcrySof(R) IQ intraocular lens (IOL) ...

The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...

PanOptix, the first and only advanced trifocal lens for U.S. patients undergoing cataract surgery, will be showcased in educational events and clinical data presentations First-ever analyses on IOLs ...

This single-arm study provided one intervention: use of the dual-zone autokeratometry feature of the Lenstar LS 900® biometer as the basis for toric IOL selection. This met the current standard of ...

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...